TY - JOUR
T1 - Temporal trends and long-term outcomes among recipients of cardiac resynchronization therapy with defibrillator in the United States, 2011–2015
T2 - Insights from the National Cardiovascular Data Registry
AU - Darden, Douglas
AU - Peterson, Pamela N.
AU - Xin, Xin
AU - Munir, Muhammad Bilal
AU - Minges, Karl E.
AU - Goldenberg, Ilan
AU - Poole, Jeanne E.
AU - Feld, Gregory K.
AU - Birgersdotter-Green, Ulrika
AU - Curtis, Jeptha P.
AU - Hsu, Jonathan C.
N1 - Publisher Copyright:
© 2022 Heart Rhythm Society
PY - 2022/8
Y1 - 2022/8
N2 - Background: Contemporary data on national trends and outcomes in cardiac resynchronization therapy with defibrillator (CRT-D) recipients following the 2012 updated guidelines has not been studied. Objectives: This study assessed the trends in long-term outcomes among CRT-D Medicare-aged recipients implanted in 2011–2015. Methods: Patients aged ≥65 years undergoing de novo CRT-D implantation in the National Cardiovascular Data Implantable Cardiac Defibrillator Registry from 2011–2015 with follow-up through 2017 using Medicare data were included and stratified by year of implant. Patient characteristics, in-hospital outcomes, and outcomes up to 2 years following implant were evaluated. Results: Among 53,174 patients (aged 75.6–6.4 years, 29.7% women) implanted with CRT-D from 2011 to 2015, there was an increase in implantations based on guideline-concordant recommendations (81.0% to 84.7%, P < .001). Compared to 2011, in-hospital procedural complications decreased in 2015 (3.9% vs 2.9%; adjusted odds ratio, 0.76, 95% confidence interval, 0.66–0.88, P < .001), driven in part by decreased lead dislodgement (1.4% vs 1.0%). After multivariable adjustment, there was a lower risk of all-cause hospitalization, cardiovascular hospitalization, and mortality at 2-year follow-up in 2015 as compared to 2011, while there were no differences in heart failure hospitalizations at follow-up. Conclusion: Among Medicare beneficiaries receiving CRT-D from 2011 to 2015, there was an increase in implantations based on guideline-concordant recommendations. Furthermore, there has been a reduction in in-hospital complications and long-term outcomes, including cardiovascular hospitalization, all-cause hospitalization, and mortality; however, there has been no difference in the risk of heart failure hospitalization after adjustment.
AB - Background: Contemporary data on national trends and outcomes in cardiac resynchronization therapy with defibrillator (CRT-D) recipients following the 2012 updated guidelines has not been studied. Objectives: This study assessed the trends in long-term outcomes among CRT-D Medicare-aged recipients implanted in 2011–2015. Methods: Patients aged ≥65 years undergoing de novo CRT-D implantation in the National Cardiovascular Data Implantable Cardiac Defibrillator Registry from 2011–2015 with follow-up through 2017 using Medicare data were included and stratified by year of implant. Patient characteristics, in-hospital outcomes, and outcomes up to 2 years following implant were evaluated. Results: Among 53,174 patients (aged 75.6–6.4 years, 29.7% women) implanted with CRT-D from 2011 to 2015, there was an increase in implantations based on guideline-concordant recommendations (81.0% to 84.7%, P < .001). Compared to 2011, in-hospital procedural complications decreased in 2015 (3.9% vs 2.9%; adjusted odds ratio, 0.76, 95% confidence interval, 0.66–0.88, P < .001), driven in part by decreased lead dislodgement (1.4% vs 1.0%). After multivariable adjustment, there was a lower risk of all-cause hospitalization, cardiovascular hospitalization, and mortality at 2-year follow-up in 2015 as compared to 2011, while there were no differences in heart failure hospitalizations at follow-up. Conclusion: Among Medicare beneficiaries receiving CRT-D from 2011 to 2015, there was an increase in implantations based on guideline-concordant recommendations. Furthermore, there has been a reduction in in-hospital complications and long-term outcomes, including cardiovascular hospitalization, all-cause hospitalization, and mortality; however, there has been no difference in the risk of heart failure hospitalization after adjustment.
KW - Cardiac resynchronization therapy
KW - Implantable cardiac defibrillator
KW - Outcomes research
KW - Registries
KW - Trends
UR - http://www.scopus.com/inward/record.url?scp=85136273645&partnerID=8YFLogxK
U2 - 10.1016/j.hroo.2022.03.004
DO - 10.1016/j.hroo.2022.03.004
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 36097450
AN - SCOPUS:85136273645
SN - 2666-5018
VL - 3
SP - 405
EP - 414
JO - Heart Rhythm O2
JF - Heart Rhythm O2
IS - 4
ER -